Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
34.5 GBX | -6.76% | -10.39% | -43.44% |
Mar. 15 | Premier Veterinary Group Announces Conclusion of Formal Sale Process | CI |
2023 | Premier Veterinary Group plc to Undertake A Formal Review of the Various Strategic Options | CI |
Valuation
Fiscal Period: September | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 6.292 | 11.28 | 7.29 | 5.295 | 5.295 | 5.295 |
Enterprise Value (EV) 1 | 3.074 | 11.63 | 10.45 | 7.381 | 3.94 | 3.967 |
P/E ratio | 3.83 x | -3.16 x | -2.49 x | -3.81 x | -5.21 x | 6.41 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 2.48 x | 3.58 x | 1.89 x | 1.32 x | 0.51 x | 0.5 x |
EV / Revenue | 1.21 x | 3.69 x | 2.71 x | 1.85 x | 0.38 x | 0.37 x |
EV / EBITDA | -0.75 x | -3.39 x | -4.36 x | -8.12 x | 1.22 x | 1.41 x |
EV / FCF | -1.82 x | -5.11 x | -6.86 x | 16.7 x | 0.47 x | -16.9 x |
FCF Yield | -55% | -19.6% | -14.6% | 5.99% | 213% | -5.93% |
Price to Book | 1.9 x | -44.4 x | -2.25 x | -1.15 x | -1.21 x | -1.51 x |
Nbr of stocks (in thousands) | 15,347 | 15,347 | 15,347 | 15,347 | 15,347 | 15,347 |
Reference price 2 | 0.4100 | 0.7350 | 0.4750 | 0.3450 | 0.3450 | 0.3450 |
Announcement Date | 12/6/17 | 2/14/19 | 3/5/20 | 9/14/21 | 10/6/22 | 1/6/23 |
Income Statement Evolution (Annual data)
Fiscal Period: September | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 2.534 | 3.152 | 3.861 | 3.997 | 10.28 | 10.59 |
EBITDA 1 | -4.097 | -3.43 | -2.397 | -0.909 | 3.242 | 2.807 |
EBIT 1 | -4.108 | -3.496 | -2.455 | -0.95 | 3.194 | 2.687 |
Operating Margin | -162.12% | -110.91% | -63.58% | -23.77% | 31.06% | 25.37% |
Earnings before Tax (EBT) 1 | -4.269 | -3.598 | -2.959 | -1.681 | -1.08 | 0.733 |
Net income 1 | 1.621 | -3.567 | -2.926 | -1.39 | -1.136 | 0.922 |
Net margin | 63.97% | -113.17% | -75.78% | -34.78% | -11.05% | 8.7% |
EPS 2 | 0.1071 | -0.2324 | -0.1907 | -0.0906 | -0.0663 | 0.0538 |
Free Cash Flow 1 | -1.69 | -2.277 | -1.524 | 0.4424 | 8.402 | -0.2352 |
FCF margin | -66.7% | -72.25% | -39.48% | 11.07% | 81.7% | -2.22% |
FCF Conversion (EBITDA) | - | - | - | - | 259.15% | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 12/6/17 | 2/14/19 | 3/5/20 | 9/14/21 | 10/6/22 | 1/6/23 |
Balance Sheet Analysis
Fiscal Period: September | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 0.35 | 3.16 | 2.09 | - | - |
Net Cash position 1 | 3.22 | - | - | - | 1.36 | 1.33 |
Leverage (Debt/EBITDA) | - | -0.1026 x | -1.32 x | -2.295 x | - | - |
Free Cash Flow 1 | -1.69 | -2.28 | -1.52 | 0.44 | 8.4 | -0.24 |
ROE (net income / shareholders' equity) | -173% | -234% | 168% | 35.5% | 24% | -21% |
ROA (Net income/ Total Assets) | -65.5% | -71.6% | -89.3% | -21.2% | 24.6% | 12.8% |
Assets 1 | -2.474 | 4.982 | 3.277 | 6.558 | -4.626 | 7.199 |
Book Value Per Share 2 | 0.2200 | -0.0200 | -0.2100 | -0.3000 | -0.2800 | -0.2300 |
Cash Flow per Share 2 | 0.2100 | 0.0400 | 0.0400 | 0.1500 | 0.4600 | 0.4600 |
Capex 1 | 0.03 | 0.01 | 0.02 | 0.02 | 0.33 | 0.02 |
Capex / Sales | 0.99% | 0.32% | 0.49% | 0.48% | 3.16% | 0.16% |
Announcement Date | 12/6/17 | 2/14/19 | 3/5/20 | 9/14/21 | 10/6/22 | 1/6/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- PVG Stock
- Financials Premier Veterinary Group plc